- Info
- Portfolio
- Significant Ownership
- Insider Ownership
Significant Ownership of Enavate Sciences GP, LLC
- Signature - Title
- /s/ James P. Boylan - By James P. Boylan, Manager
- Location
- New York, NY
- Summary
- This page shows a list of all the recent SCHEDULE 13D/G filings made by Enavate Sciences GP, LLC.
Follow Filing Activity
Follow Enavate Sciences GP, LLC and return when a new Schedule 13D/G filing appears.
This tracks SEC filing changes for this page using existing product update flows.
Continue schedule research
Related filing hubs for this reporting manager, useful for reinforcing crawl paths across the schedule cluster.
Significant Ownership of Enavate Sciences GP, LLC
| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ZBIO | Zenas BioPharma, Inc. | Common Stock, par value $0.0001 per share | 7.3% | $87,013,952 | 3,919,159 | Enavate Sciences GP, LLC | 09 Oct 2025 | ||
| SION | SIONNA THERAPEUTICS, INC. | Common Stock, $0.001 par value per share | 5.6% | $29,835,481 | 2,478,030 | Enavate Sciences GP, LLC | 10 Feb 2025 | ||
| CAMP | CAMP4 THERAPEUTICS CORPORATION | Common Stock, $0.0001 par value per share | 4.8% | $10,955,517 | -$2,773,593 | 2,495,562 | -20% | Enavate Sciences GP, LLC | 09 Mar 2026 |
| IMNM | IMMUNOME, INC. | Common Stock, par value $0.0001 per share | 4.3% | $73,483,864 | 4,768,583 | Enavate Sciences GP, LLC | 18 Dec 2025 |
Schedules 13D/G Reported by Enavate Sciences GP, LLC:
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Filing Date |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.